Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024): Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type (Testing Strips, Glucometers, Others) End-User Type and Countries” report has been added to ResearchAndMarkets.com’s offering. The Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the … [Read more…]

Pros and Cons of Predictive Analytics in Healthcare | Quantzig’s Latest Article Offers Expert Insights

LONDON–(BUSINESS WIRE)–#Analytics–Quantzig, a leading analytics advisory firm that delivers customized analytics solutions, has announced the completion of their article that lists the pros and cons of predictive analytics in healthcare. With the healthcare sector beginning to leverage advanced technologies such as predictive analytics and AI, healthcare organizations, health care agencies, and primary healthcare service providers … [Read more…]

Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application: Analysis & Outlook, 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application Outlook 2024” report has been added to ResearchAndMarkets.com’s offering. CRISPR is one such technology that has totally revolutionized the working process in the scientific field. It has been only a few years since its discovery and CRISPR has started dominating the research labs all … [Read more…]

Global Gene Therapy Technologies, Companies & Markets During the Forecast Period, 2018-2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gene Therapy – Technologies, Markets & Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’soffering. Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes and DNA are now … [Read more…]

TigerConnect Recognized as One of the Best Places to Work in Healthcare for the Fifth Consecutive Year

SANTA MONICA, Calif.–(BUSINESS WIRE)–TigerConnect, provider of healthcare’s most advanced, reliable, and widely adopted care team collaboration solution, has been selected by Modern Healthcare as one of the 2019 Best Places to Work in Healthcare for the fifth consecutive year. The complete list of this year’s winner rankings is available here. Modern Healthcare published a special … [Read more…]

Copay Accumulator Adjustment Programs Driving Patients to Phototherapy and Other Alternatives to Prescription Drugs, Reports National Biological Corporation

BEACHWOOD, Ohio–(BUSINESS WIRE)–Many patients rely on copay cards and coupons from pharmaceutical companies to manage the out of pocket cost of expensive prescription drugs. Until recently, these manufacturer subsidies often counted towards patients’ deductible limits. Now, through the use of copay accumulator adjustment programs (CAAPs), many insurance plans no longer count manufacturer subsidies toward deductible … [Read more…]

Drug Delivery in Cancer: Technologies, Companied and Markets, 2018-2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Drug Delivery in Cancer – Technologies, Markets & Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. Drug delivery remains a challenge in the management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery for cancer. … [Read more…]

Global Nitric Oxide 2019: Therapeutics, Companies and Markets – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Nitric Oxide – Therapeutics, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based drugs … [Read more…]

Global Personalized Medicine – Scientific & Commercial Aspects, 2018-2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Personalized Medicine – Scientific & Commercial Aspects” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This … [Read more…]

VirTrial Awarded FDA-Approved Decentralized Clinical Trial with Hope Biosciences

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#Clinicaltrials—VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSCs) for the treatment of spinal cord injury/disorder (SCI/D). Study protocol incorporates remote visits via VirTrial’s telehealth platform. “After reviewing countless vendors, we found that VirTrial met our … [Read more…]